Cytokinetics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Cytokinetics Inc.
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
/ 
Frequently asked questions
To buy Cytokinetics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Cytokinetics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Cytokinetics Inc. is CYTK:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Cytokinetics Inc. has its primary listing on NASDAQ. You can trade Cytokinetics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Cytokinetics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Cytokinetics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Cytokinetics Inc..